{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:18:25Z","timestamp":1770063505114,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1C1B2011815"],"award-info":[{"award-number":["2016R1C1B2011815"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["0420160640"],"award-info":[{"award-number":["0420160640"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183491","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T20:03:35Z","timestamp":1503345815000},"page":"e0183491","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies"],"prefix":"10.1371","volume":"12","author":[{"given":"Jeonghwan","family":"Youk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ah","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-6201","authenticated-orcid":true,"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"32","author":"DL Hershman","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"S Quasthoff","year":"2002","journal-title":"Journal of Neurology"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"M Seretny","year":"2014","journal-title":"Pain"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.1992.10.5.795","article-title":"Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity","volume":"10","author":"RW Gregg","year":"1992","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/A:1008231925889","article-title":"Carboplatin toxic effects on the peripheral nervous system of the rat","volume":"9","author":"G Cavaletti","year":"1998","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1995.1008","article-title":"Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol","volume":"133","author":"G Cavaletti","year":"1995","journal-title":"Exp Neurol"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archneur.1994.00540190110024","article-title":"Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings","volume":"51","author":"Z Sahenk","year":"1994","journal-title":"Archives of neurology"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/107327480301000502","article-title":"Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers.","volume":"10","author":"PG Richardson","year":"2003","journal-title":"Cancer control: journal of the Moffitt Cancer Center"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/EDR.2003.271","article-title":"Nerve Growth Factor and Diabetic Neuropathy","volume":"4","author":"AV Gary Pittenger","year":"2003","journal-title":"Experimental Diab Res"},{"issue":"8752","key":"ref10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0140-6736(91)92921-N","article-title":"New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides","volume":"337","author":"P Anand","year":"1991","journal-title":"Lancet"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0696-703","article-title":"The role of endogenous nerve growth factor in human diabetic neuropathy","volume":"2","author":"P Anand","year":"1996","journal-title":"Nature medicine"},{"issue":"1","key":"ref12","first-page":"90","article-title":"Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor","volume":"6","author":"S De Santis","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","article-title":"Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy","volume":"15","author":"G Cavaletti","year":"2004","journal-title":"Annals of Oncology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.410310114","article-title":"Nerve growth factor prevents experimental cisplatin neuropathy","volume":"31","author":"SC Apfel","year":"1992","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"ref15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1566-0702(00)00247-2","article-title":"Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis","volume":"86","author":"L Aloe","year":"2000","journal-title":"Autonomic neuroscience: basic & clinical"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0014-4886(95)90054-3","article-title":"Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db\/db) mice","volume":"132","author":"Y Schmidt","year":"1995","journal-title":"Exp Neurol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/exnr.1999.7174","article-title":"Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats","volume":"159","author":"G Tredici","year":"1999","journal-title":"Exp Neurol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410290115","article-title":"Nerve growth factor prevents toxic neuropathy in mice","volume":"29","author":"SC Apfel","year":"1991","journal-title":"Ann Neurol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. Journal of the peripheral nervous system","volume":"13","author":"V Chaudhry","year":"2008","journal-title":"JPNS"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"BG Durie","year":"2006","journal-title":"Leukemia"},{"issue":"27","key":"ref21","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"BD Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref22","unstructured":"Cleeland C, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore. 1994;23(2):129\u201338."},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/00031305.1998.10480559","article-title":"Violin Plots: A Box Plot-Density Trace Synergism","volume":"52","author":"JL Hintze","year":"1998","journal-title":"The American Statistician"},{"issue":"9","key":"ref24","first-page":"619","article-title":"Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies","volume":"12","author":"AJ Ocean","year":"2004","journal-title":"Support Care Cancer"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: A current review","volume":"81","author":"NP Staff","year":"2017","journal-title":"Ann Neurol"},{"issue":"6","key":"ref26","first-page":"419","article-title":"Chemotherapy\u2010induced peripheral neurotoxicity: A critical analysis","volume":"63","author":"SB Park","year":"2013","journal-title":"CA: a cancer journal for clinicians"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3940(02)00091-5","article-title":"Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor","volume":"322","author":"G Cavaletti","year":"2002","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"ref28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(97)81682-4","article-title":"Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice","volume":"774","author":"PC Contreras","year":"1997","journal-title":"Brain Res"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB. Potent analgesic effects of GDNF in neuropathic pain states. Science (New York, NY). 2000;290(5489):124\u20137.","DOI":"10.1126\/science.290.5489.124"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"e0139394","DOI":"10.1371\/journal.pone.0139394","article-title":"Corneal confocal microscopy detects small fibre neuropathy in patients with upper gastrointestinal cancer and nerve regeneration in chemotherapy induced peripheral neuropathy","volume":"10","author":"M Ferdousi","year":"2015","journal-title":"PloS one"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/WCO.0b013e32835804c5","article-title":"Small fibre neuropathy","volume":"25","author":"G Lauria","year":"2012","journal-title":"Current opinion in neurology"},{"issue":"17","key":"ref32","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.284.17.2215","article-title":"Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial","volume":"284","author":"SC Apfel","year":"2000","journal-title":"Jama"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"SC Apfel","year":"2002","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.54.5.1080","article-title":"A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection","volume":"54","author":"J McArthur","year":"2000","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2014.09.005","article-title":"Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR","volume":"45","author":"A Friesland","year":"2014","journal-title":"Neurotoxicology"},{"key":"ref36","first-page":"373","article-title":"Anti-nerve growth factor in pain management: current evidence","volume":"9","author":"DS Chang","year":"2016","journal-title":"Journal of Pain Research"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.106.116236","article-title":"Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance","volume":"322","author":"KD Wild","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1073\/pnas.0611253104","article-title":"The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain","volume":"104","author":"G Ugolini","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1479-5876-10-239","article-title":"Nerve growth factor: from the early discoveries to the potential clinical use","volume":"10","author":"L Aloe","year":"2012","journal-title":"Journal of Translational Medicine"},{"key":"ref40","unstructured":"A Phase 3 Study of Tanezumab for Chronic Low Back Pain (TANGO), available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02528253\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02528253<\/ext-link>"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-6-5","article-title":"Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study","volume":"6","author":"S Pignata","year":"2006","journal-title":"BMC cancer"},{"issue":"13","key":"ref42","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"EML Smith","year":"2013","journal-title":"Jama"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:49:30Z","timestamp":1719402570000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183491"}},"subtitle":[],"editor":[{"given":"Rayaz Ahmed","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183491","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]}}}